Neoplasms

Digestive System Diseases

Gland and Hormone Related Diseases

All Conditions

Symptoms and General Pathology

Nervous System Diseases

Rare Diseases

Pancreatic Neoplasms

Fistula

Gastroparesis

Anastomotic Leak

Pancreatic Fistula

Gastrointestinal Neoplasms

Digestive System Neoplasms

Endocrine Gland Neoplasms

Gastrointestinal Diseases

Pancreatic Diseases

Endocrine System Diseases

Pathological Conditions, Anatomical

Digestive System Fistula

Postoperative Complications

Stomach Diseases

Paralysis

Neurologic Manifestations

Pancreatic Cancer

Intravenous human albumin 1g/kg at skin incision running at 100ml/hour

Intravenous human albumin given at a maximum dose of 1g/kg at skin incision which is infused at 100ml/hour

Human albumin

Ian Chik

Sarah I Liew

Sarah I Liew, MBBS

Farrah-Hani Imran

Azarinah Izaham

Zamri Zuhdi

Azlanuddin Azman

Razman Jarmin

Fahrol F Jaafar

Pancreaticoduodenectomy (PD), more commonly known as Whipple's surgery is the mainstay treatment for pancreatic head and periampullary cancer. Factors contributing to PD outcomes are broadly categorized to disease-related, patient-related and operative factors. Whereas an inexhaustible list of study exists on looking at reducing PD complication rates with respect to the above-mentioned factors, it was only recently that more attention has been given to the impact of perioperative and intraoperative fluid regimes on PD outcomes. This study takes interest in the impact of intraoperative fluid regimes on PD outcomes. The objective of this investigation is to compare the outcomes with the use of intraoperative intravenous human albumin versus standard intraoperative fluid regimes.

This is a randomized controlled trial being conducted at the Universiti Kebangsaan Malaysia Medical Center (UKMMC) with two arms; the control and treatment arms. The treatment arm will receive intravenous human albumin intraoperatively whilst the control arm will receive standard intraoperative fluid regimes. Primary endpoint will be overall complication rates whilst secondary endpoints are length of hospitalization, length of ICU care, duration of gastroparesis, pancreatic fistula rates, surgical site infection rates, duration of surgery and intraoperative bleeding.

Beyond the intraoperative fluid regimes, postoperative care follows the standardised UKMMC Enhanced Recovery After Surgery (ERAS) protocols which saw an improvement in overall outcomes in patients who underwent pancreaticoduodenectomies (PD). Preoperative care will include nutrition optimisation, counselling, antimicrobial prophylaxis, perioperative glycemic control and near-zero fluid balance.

Data collection will include:

i. preoperative data: age, sex, ethnicity, BMI on admission, date of admission, comorbidities and the New York Heart Association (NYHA) functional status classification. Further information will include biochemical markers such as serum albumin albumin, white cell count (WCC), renal functions.

ii. Intraoperative information: duration of surgery, estimated blood loss, pancreatic duct size, pancreatic texture, amount and type of fluid administered, fluid balances and type of anastomoses.

iii. postoperative data: fluid balances and renal function of postoperative day 1 to 3, duration of ICU stay, readmission to ICU, length of hospital stay, duration to standard feeds, grading of pancreatic fistula (where relevant), surgical site infection, duration to removal of urinary catheter, cardiac complications, renal and pulmonary complications, deep vein thrombosis, re-operation, and mortality.

This is a randomized controlled trial conducted at the University Kebangsaan Malaysia Medical Center (UKMMC) with two arms; a control a treatment arm. The treatment arm will receive intravenous human albumin intraoperatively whilst the control arm will receive standard intraoperative fluid regimes.

Intravenous Human Albumin In Improving Pancreaticoduodenectomy Outcomes

Complications are defined as any deviation from the normal postoperative course, graded from I to V following the Clavien-Dindo classification of complications whereby Grade I are mild complications not needing any additional interventions and Grade V equates to the most severe complication which is death.

Duration of stay in ICU (in days), where relevant

Rates of postoperative pancreatic fistula

Measured in duration of surgery (in hours \& mins)

Universiti Kebangsaan Malaysia Medical Centre

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Intravenous Human Albumin In Improving Pancreaticoduodenectomy Outcomes	NCT04418739	Pancreaticoduod... Pancreatic Fist... Delayed Gastric... Pancreatic Canc... Anastomotic Lea...	Human albumin	-	Universiti Kebangsaan Malaysia Medical Centre
Intravenous Human Albumin In Improving Pancreaticoduodenectomy Outcomes	NCT04418739	Pancreaticoduod... Pancreatic Fist... Delayed Gastric... Pancreatic Canc... Anastomotic Lea...	Human albumin	-	Universiti Kebangsaan Malaysia Medical Centre

Spots Global Cancer Trial Database for intravenous human albumin